202 related articles for article (PubMed ID: 32032495)
21. Reply to Sun
Sun YY; Wang L; Liu JM; Yuan P
Am J Respir Crit Care Med; 2022 Jan; 205(2):254. PubMed ID: 34739352
[No Abstract] [Full Text] [Related]
22. COUNTERPOINT: Should Initial Combination Therapy Be the Standard of Care in Pulmonary Arterial Hypertension? No.
Channick RN; Saggar R
Chest; 2019 Dec; 156(6):1043-1045. PubMed ID: 31812189
[No Abstract] [Full Text] [Related]
23. Finding the needle in the haystack: BMP9 and 10 emerge from the genome in pulmonary arterial hypertension.
Morrell NW
Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30872557
[No Abstract] [Full Text] [Related]
24. PDA with Eisenmenger Syndrome Masquerading as Idiopathic Pulmonary Hypertension.
Niveditha ; Kasal S
J Assoc Physicians India; 2020 Jan; 68(1):53. PubMed ID: 31979585
[No Abstract] [Full Text] [Related]
25. Transthoracic Pulmonary Artery Denervation.
Ogo T
Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):979-981. PubMed ID: 31116607
[No Abstract] [Full Text] [Related]
26. [Research progress on the role of gas signal molecules on pulmonary arterial hypertension].
Wang MJ; Tang YY; Yu ZX
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jan; 50(1):14-19. PubMed ID: 35045609
[TBL] [Abstract][Full Text] [Related]
27. Toward Harnessing Sex Steroid Signaling as a Therapeutic Target in Pulmonary Arterial Hypertension.
Lahm T; Frump AL
Am J Respir Crit Care Med; 2017 Feb; 195(3):284-286. PubMed ID: 28145752
[No Abstract] [Full Text] [Related]
28. Adding an important piece to the pulmonary vascular resistance puzzle in pulmonary arterial hypertension.
Maron BA; Humbert M
Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32646896
[No Abstract] [Full Text] [Related]
29. Postural changes from ventilatory gas exchange in pulmonary hypertension: Is it a practical solution to a complex question?
Rivera-Lebron BN; Cruz Morel KJ; Risbano MG
Respirology; 2020 Apr; 25(4):354-355. PubMed ID: 31454132
[No Abstract] [Full Text] [Related]
30. Assessing the cancer hypothesis of pulmonary arterial hypertension: the devil is in the detail.
Frump AL; Lai YC; Lahm T
Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1140-L1141. PubMed ID: 32186392
[No Abstract] [Full Text] [Related]
31. Pulmonary Hypertension Associated With Respiratory Diseases - Which Patients Should Be Treated With Pulmonary Arterial Hypertension-Targeted Therapies?
Sakamaki F; Asano K
Circ J; 2021 Mar; 85(4):343-344. PubMed ID: 33563867
[No Abstract] [Full Text] [Related]
32. Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension.
Declercq M; Treps L; Bousfia S; Carmeliet P; Witters P
Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 34385264
[No Abstract] [Full Text] [Related]
33. Know your enemy: understanding the pathophysiology of pulmonary hypertension.
Shimoda LA
Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L995-L997. PubMed ID: 32233788
[No Abstract] [Full Text] [Related]
34. Clarifying the Pulmonary Arterial Hypertension Molecular Landscape Using Functional Genetics.
Maron BA
Am J Respir Crit Care Med; 2020 Aug; 202(4):488-490. PubMed ID: 32453600
[No Abstract] [Full Text] [Related]
35. Pulmonary Arterial Hypertension and Specialty Care Centers: We Had a Feeling; Now We Have Data.
Chakinala MM; Farber HW
Chest; 2020 Jul; 158(1):28-30. PubMed ID: 32654707
[No Abstract] [Full Text] [Related]
36. Initial triple therapy in pulmonary arterial hypertension: coming of age and rejuvenated.
Bogaard HJ; Sitbon O
Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 33509909
[No Abstract] [Full Text] [Related]
37. Response by Kikuchi et al Regarding Article, "Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target".
Kikuchi N; Satoh K; Saito Y; Shimokawa H
Circulation; 2019 Jan; 139(5):724-725. PubMed ID: 30689421
[No Abstract] [Full Text] [Related]
38. Decoding the Link Between Inflammation and Pulmonary Arterial Hypertension.
Zhong Y; Yu PB
Circulation; 2022 Sep; 146(13):1023-1025. PubMed ID: 36154621
[No Abstract] [Full Text] [Related]
39. The cancer hypothesis of pulmonary arterial hypertension: the next ten years.
Condon D; Agarwal S; Chakraborty A; de Jesus Perez VA
Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1138-L1139. PubMed ID: 32186209
[No Abstract] [Full Text] [Related]
40. Letter by Nadeau et al Regarding Article, "Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension".
Nadeau V; Bonnet S; Paulin R
Circulation; 2019 Aug; 140(7):e286-e287. PubMed ID: 31403848
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
